Whether you are testing nebulizers, using biologics, or seeking more efficient cleaning methods, the Next Generation Impactor (NGI+) opens up new possibilities for improving your inhalation testing processes.
Nebulizer Testing
Nebulizer solutions are becoming increasingly popular, especially for patients with severely limited breathing capacities. These solutions often involve the suspension of live molecules or proteins, making them ideal for biologics. However, testing these solutions can be challenging due to their corrosive nature.
How does the NGI+ benefit nebulizer testing?
The NGI+ is designed to withstand the corrosive saline mixtures commonly used in nebulizer solutions, ensuring accurate and reliable testing results. This makes it an ideal choice for evaluating the performance of nebulizers and ensuring that they deliver the intended therapeutic benefits.
Robust Cleaning Methods
Cleaning testing equipment is a critical but often overlooked aspect of the particle collection process. Proper cleaning is essential to avoid cross-contamination between tests and to ensure consistent and accurate results.
How does the NGI+ improve cleaning processes?
The NGI+ features enhanced corrosion resistance, allowing for the use of harsher cleaning chemicals and enabling automated cleaning solutions. This not only shortens the cleaning process but also ensures that the equipment remains in optimal condition, providing reliable results over a longer period.
Benefits of Advanced Inhalation Testing
- Enhanced Accuracy: Improved materials and design ensure precise testing results, crucial for developing effective inhalation therapies.
- Increased Efficiency: Robust and automated cleaning methods save time and reduce the risk of cross-contamination, leading to more consistent data.
- Versatility: The NGI+ can handle a wide range of applications, from nebulizers to biologics, making it a versatile tool for various testing scenarios.
- Longevity: Enhanced corrosion resistance extends the life expectancy of the equipment, ensuring long-term reliability and performance.
By focusing on the application and testing benefits, the NGI+ helps researchers and developers achieve more accurate, efficient, and reliable results in inhalation therapy testing. This ultimately leads to better therapeutic outcomes for patients and advances in respiratory care.